Skip to content
healthcare.dev

Doxazosin

NDC 60505-0093, Doxazosin, tablet, from Apotex Corp..

Product NDC
60505-0093
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075580
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-0093 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE1 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
60505-0093-060505009300100 TABLET in 1 BOTTLE (60505-0093-0)
60505-0093-1605050093011000 TABLET in 1 BOTTLE (60505-0093-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b
  • NADAC price for package 60505009300

    GET /v1/drugs/nadac/60505009300
  • NADAC price for package 60505009301

    GET /v1/drugs/nadac/60505009301

Use it

Look up 60505-0093 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-0093 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-0093. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.